The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
Su Yin Lim(The University of Sydney), Helen Rizos(Macquarie University)
Cited by 127
Related Papers
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
|Nature Communications|2014|385
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
|The Lancet Oncology|2019|219
Inhibition of mTORC1/2 Overcomes Resistance to MAPK Pathway Inhibitors Mediated by PGC1α and Oxidative Phosphorylation in Melanoma
|Cancer Research|2014|205